Phenotypic and genotypic study of macrolide, lincosamide and streptogramin b (MLSB) resistance in clinical isolates of staphylococcus aureus in tehran, Iran

Medical Science Monitor

Volumn 17, Issue 2, 2011, Pages

  Saderi, Horieh ^a   Emadi, Behzad ^a   Owlia, Parviz ^a  

^a SHAHED UNIVERSITY   (Iran)

Author keywords

Clindamycin; D test; ermA; ermC; Erythromycin; Staphylococcus aureus

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN; LINCOSAMIDE; MIKAMYCIN B;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CONTROLLED STUDY; DISK DIFFUSION; ERMA GENE; ERMC GENE; GENE IDENTIFICATION; GENOTYPE; IRAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; NUC GENE; PHENOTYPE;

EID: 79551695452     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.881386     Document Type: Article

References (29)

1. Leclercq R: Mechanisms of resistance to macrolides and lincosamides: Nature of the resistance elements and their clinical implications. Clin Infect Dis, 2002; 34: 482-92
2. Fiebelkorn KR, Crawford SA, McElmeel ML, Jorgensen JH: Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol, 2003; 41: 4740-44
3. Lina G, Quaglia A, Reverdy ME et al: Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci. Antimicrob Agents Chemother, 1999; 43(5): 1062-66
4. Kasten MJ: Clindamycin, metronidazole, and chloramphenicol. Mayo Clin Proc, 1999; 74: 825-33
5. Weisblum B: Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother, 1995; 39: 577-85
6. Roberts MC, Sutcliffe J, Courvalin P et al: Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob Agents Chemother, 1999; 43: 2823-30
7. Daurel C, Huet C, Dhalluin A et al: Differences in potential for selection of clindamycin-resistant mutants between inducible erm(A) and erm(C) Staphylococcus aureus genes. J Clin Microbiol, 2008; 46(2): 546-50
8. Levin TP, Suh B, Axelrod P et al: Potential clindamycin resistance in clindamycin-susceptible, erythromycin-resistant Staphylococcus aureus: report of a clinical failure. Antimicrob Agents Chemother, 2005; 49(3): 1222-24
9. Drinkovic D, Fuller ER, Shore KP et al: Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance. J Antimicrob Chemother, 2001; 48(2): 315-16
10. Frank AL, Marcinak JF, Mangat PD et al: Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr Infect Dis J, 2002; 21: 530-34
11. Siberry GK, Tekle T, Carroll K, Dick J: Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis, 2003; 37(9): 1257-60
12. Panagea S, Perry JD, Kate Gould F: Should clindamycin be used as treatment of patients with infections caused by erythromycin-resistant staphylococci? J Antimicrob Chemother, 1999; 44: 581-82
13. Clinical and Laboratory Standards Institute (CLSI). 2005. Performance standards for antimicrobial susceptibility tests; Fifteenth informational supplement. CLSI document M100-S15. Vol. 25, No. 1. Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, USA
14. Perez-Roth E, Claverie-Martin F, Villar J, Mendez-Alvarez S: Multiplex PCR for simultaneous identification of Staphylococcus aureus and detection of methicillin and mupirocin resistance. J Clin Microb, 2001; 39: 4037-41
15. Zhang K, Sparling J, Chow BL et al: New quadriplex PCR assay for detection of methicillin and mupirocin resistance and simultaneous discrimination of Staphylococcus aureus from coagulase-negative staphylococci. J Clin Microbiol, 2004; 42(11): 4947-55
16. Spiliopoulou I, Petinaki E, Papandreou P, Dimitracopoulos G: erm(C) is the predominant genetic determinant for the expression of resistance to macrolides among methicillin-resistant Staphylococcus aureus clinical isolates in Greece. J Antimicrob Chemother, 2004; 53(5): 814-17
17. Yilmaz G, Aydin K, Iskender S et al: Detection and prevalence of inducible clindamycin resistance in staphylococci. J Med Microbiol, 2007; 56: 342-45
18. Schmitz FJ, Verhoef J, Fluit AC: Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SENTRY surveillance programme. Sentry Participants Group. J Antimicrob Chemother, 1999; 43: 783-92
19. Saderi H, Owlia P, Habibi M: Mupirocin resistance among Iranian isolates of Staphylococcus aureus. Med Sci Monit, 2008; 14(10): BR210-13
20. Rahbar M, Hajia M: Inducible clindamycin resistance in Staphylococcus aureus: a cross-sectional report. Pak J Biol Sci, 2007; 10(1): 189-92
21. Delialioglu N, Aslan G, Ozturk C et al: Inducible clindamycin resistance in staphylococci isolated from clinical samples. Jpn J Infect Dis, 2005; 58: 104-6
22. Schreckenberger PC, Ilendo E, Ristow KL: Incidence of constitutive and inducible clindamycin resistance in Staphylococcus aureus and coagulase- negative staphylococci in a community and a tertiary care hospital. J Clin Microbiol, 2004; 42: 2777-79
23. Zelazny AM, Ferraro MJ, Glennen A et al: Selection of strains for quality assessment of the disk induction method for detection of inducible clindamycin resistance in Staphylococci: a CLSI collaborative study. J Clin Microbiol, 2005; 43(6): 2613-15
24. Martineau F, Picard FJ, Lansac N et al: Correlation between the resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother, 2000; 44(2): 231-38
25. Schmitz FJ, Sadurski R, Kray A et al: Prevalence of macrolide-resistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals. J Antimicrob Chemother, 2000; 45(6): 891-94
26. Westh H, Hougaard DM, Vuust J, Rosdahl VT: Erm genes in erythromycin- resistant Staphylococcus aureus and coagulase-negative staphylococci. APMIS, 1995; 103: 225-32
27. Aktas Z, Aridogan A, Kayacan CB, Aydin D: Resistance to macrolide, lincosamide and streptogramin antibiotics in staphylococci isolated in Istanbul, Turkey. J Microbiol, 2007; 45(4): 286-90
28. Gul HC, Kilic A, Guclu AU et al: Macrolide-lincosamide-streptogramin B resistant phenotypes and genotypes for methicillin-resistant Staphylococcus aureus in Turkey, from 2003 to 2006. Pol J Microbiol, 2008; 57(4): 307-12
29. Otsuka T, Zaraket H, Takano T et al: Macrolide-lincosamide-streptogramin B resistance phenotypes and genotypes among Staphylococcus aureus clinical isolates in Japan. Clin Microbiol Infect, 2007; 13(3): 325-27